Patents by Inventor Errol B. DeSouza

Errol B. DeSouza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Corticotropin-releasing factor receptors
    Patent number: 7034118
    Abstract: The present invention provides isolated nucleic acid molecules encoding CRF2 receptors, recombinant expression vectors and host cells suitable for expressing such receptors, as well as compositions and methods which utilize such receptors.
    Type: Grant
    Filed: April 9, 2004
    Date of Patent: April 25, 2006
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Timothy W Lovenberg, Tilman Oltersdorf, Chen Wang Liaw, Dimitri E Grigoriadis, Derek T Chalmers, Errol B DeSouza
  • Corticotropin-releasing factor2 receptors
    Publication number: 20040185533
    Abstract: The present invention provides isolated nucleic acid molecules encoding CRF2 receptors, recombinant expression vectors and host cells suitable for expressing such receptors, as well as compositions and methods which utilize such receptors.
    Type: Application
    Filed: April 9, 2004
    Publication date: September 23, 2004
    Applicant: Neurocrine Biosciences, Inc.
    Inventors: Timothy W. Lovenberg, Tilman Oltersdorf, Chen Wang Liaw, Dimitri E. Grigoriadis, Derek T. Chalmers, Errol B. DeSouza
  • Corticotropin-releasing factor2 receptors
    Patent number: 6723841
    Abstract: The present invention provides isolated nucleic acid molecules encoding CRF2 receptors, recombinant expression vectors and host cells suitable for expressing such receptors, as well as compositions and methods which utilize such receptors.
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: April 20, 2004
    Assignee: Neurocrine Biosciences Inc.
    Inventors: Timothy W. Lovenberg, Tilman Oltersdorf, Chen Wang Liaw, Dimitri E. Grigoriadis, Derek T. Chalmers, Errol B. DeSouza
  • Corticotropin-releasing factor2 receptors
    Publication number: 20020077468
    Abstract: The present invention provides isolated nucleic acid molecules encoding CRF2 receptors, recombinant expression vectors and host cells suitable for expressing such receptors, as well as compositions and methods which utilize such receptors.
    Type: Application
    Filed: June 13, 2001
    Publication date: June 20, 2002
    Inventors: Timothy W. Lovenberg, Tilman Oltersdorf, Chen Wang Liaw, Dimitri E. Grigoriadis, Derek T. Chalmers, Errol B. DeSouza
  • Interleukin-1 type 3 receptors
    Patent number: 6239268
    Abstract: The present invention provides isolated nucleic acid molecules encoding soluble and membrane bound forms of Interleukin-1 Type 3 receptors, as well as recombinant expression vectors and host cells suitable for expressing such receptors.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: May 29, 2001
    Assignee: Neurocrine Biosciences, Inc.
    Inventors: Timothy W. Lovenberg, Tilman Oltersdorf, Chen Wang Liaw, William R. Clevenger, Errol B. DeSouza